İsMail Demirel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
İsMail Demirel has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Gülsüm Altuntaş
Department of Anesthesiology and Reanimation, Faculty of Medicine, Fırat University, Elazığ, Turkiye
2 shared publications - Ahmet Aksu
Department of Anesthesiology and Reanimation, Faculty of Medicine, Fırat University, 23119 Elazığ, Türkiye
1 shared publication - Aysun Yildiz Altun
Department of Anesthesiology and Reanimation, Faculty of Medicine, Firat University, TR23119 Elazig, Turkey
1 shared publication - Ayşe Çapar
SAĞLIK BİLİMLERİ ÜNİVERSİTESİ, İSTANBUL SULTAN ABDÜLHAMİD HAN SAĞLIK UYGULAMA VE ARAŞTIRMA MERKEZİ
1 shared publication - Erkan Çakmak
Department of Internal Medicine, Faculty of Medicine, Firat University, Elazig 23300, Turkey
1 shared publication - Esef Bolat
Department of Anaesthesiology and Reanimation, Faculty of Medicine, Firat University, Elazig, Turkey
1 shared publication
Latest Publications
- Open Access
- 31 January 2026
- Published by Springer Nature in Obesity Surgery
- Vol. 36 (3) , 1210-1219
The Impact of Intraoperative Position Changes on Hemodynamics and Cardiac Electrophysiological Balance Index in Patients with Severe Obesity Undergoing Laparoscopic Sleeve Gastrectomy
Background: Pneumoperitoneum and the reverse Trendelenburg (RT) position during laparoscopic sleeve gastrectomy (LSG) can induce autonomic instability and increase the risk of arrhythmias by reducing venous return. This study aimed to evaluate the impact of surgical positioning during LSG on autonomic cardiac function, using hemodynamic parameters and the cardiac electrophysiological balance index (iCEB = QT/QRS) as a biomarker. Methods: This prospective observational study included 66 patients with severe obesity who underwent LSG. Measurements were recorded at five distinct time points, corresponding to specific patient positioning during the procedure: P-baseline (before induction, supine), P1 (after induction, supine), P2 (after pneumoperitoneum, supine), P3 (during pneumoperitoneum, RT), and P4 (after desufflation, RT). Results: Systolic, diastolic, and mean arterial pressures (SAP, DAP, and MAP) significantly decreased at all positions compared to baseline ( p < 0.001 for each). Compared to post-induction (P1), SAP values were substantially higher in the P2 and P4 positions ( p < 0.05, p < 0.001, respectively). Heart rate significantly decreased at P1 compared to baseline ( p < 0.004) and subsequently increased at P2 and P3 relative to P1 ( p < 0.001 and p < 0.009, respectively). A notable increase in iCEB was observed at P4 when compared to P1, P2, and P3 ( p < 0.003, p < 0.001, and p < 0.021, respectively). Despite these changes, iCEB values remained within the reference range across all measured positions. Conclusion: Despite the observed effects of positional changes and pneumoperitoneum on hemodynamic and cardiac electrical parameters during LSG, most patients tolerated these changes well. Crucially, iCEB values remained within the normal reference range throughout the procedure, indicating preserved cardiac autonomic regulation.
- 31 January 2026
- Published by Springer Nature in Obesity Surgery
- Vol. 36 (3) , 1210-1219
Open AccessThe Impact of Intraoperative Position Changes on Hemodynamics and Cardiac Electrophysiological Balance Index in Patients with Severe Obesity Undergoing Laparoscopic Sleeve Gastrectomy
Background: Pneumoperitoneum and the reverse Trendelenburg (RT) position during laparoscopic sleeve gastrectomy (LSG) can induce autonomic instability and increase the risk of arrhythmias by reducing venous return. This study aimed to evaluate the impact of surgical positioning during LSG on autonomic cardiac function, using hemodynamic parameters and the cardiac electrophysiological balance index (iCEB = QT/QRS) as a biomarker. Methods: This prospective observational study included 66 patients with severe obesity who underwent LSG. Measurements were recorded at five distinct time points, corresponding to specific patient positioning during the procedure: P-baseline (before induction, supine), P1 (after induction, supine), P2 (after pneumoperitoneum, supine), P3 (during pneumoperitoneum, RT), and P4 (after desufflation, RT). Results: Systolic, diastolic, and mean arterial pressures (SAP, DAP, and MAP) significantly decreased at all positions compared to baseline ( p < 0.001 for each). Compared to post-induction (P1), SAP values were substantially higher in the P2 and P4 positions ( p < 0.05, p < 0.001, respectively). Heart rate significantly decreased at P1 compared to baseline ( p < 0.004) and subsequently increased at P2 and P3 relative to P1 ( p < 0.001 and p < 0.009, respectively). A notable increase in iCEB was observed at P4 when compared to P1, P2, and P3 ( p < 0.003, p < 0.001, and p < 0.021, respectively). Despite these changes, iCEB values remained within the reference range across all measured positions. Conclusion: Despite the observed effects of positional changes and pneumoperitoneum on hemodynamic and cardiac electrical parameters during LSG, most patients tolerated these changes well. Crucially, iCEB values remained within the normal reference range throughout the procedure, indicating preserved cardiac autonomic regulation.
- Open Access
- 27 January 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (3) , 1011
Immature Granulocyte Trajectories Following Hemadsorption as Indicators of Immune Dysregulation and Mortality
Background: Sepsis is a life-threatening condition characterized by a dysregulated host response to infection. Hemadsorption therapies remove inflammatory mediators and are used as adjunctive treatment in selected patients. Although increased immature granulocyte (IG) levels correlate with inflammatory severity, changes in IG levels after hemadsorption therapy have not been previously evaluated. Methods: This retrospective observational study included patients with sepsis who received hemadsorption therapy in intensive care units between January 2021 and July 2025. Sepsis was diagnosed according to the Surviving Sepsis Campaign 2021 guidelines, and hemadsorption was initiated for persistent hemodynamic instability despite standard therapy. Treatment was performed using a Jafron HA330 cartridge for at least three 6 h sessions. IG count and percentage, inflammatory parameters, lactate levels, and organ dysfunction scores were recorded before and after therapy. ICU mortality was the primary outcome. Statistical analyses included paired comparisons, multivariable logistic regression, and ROC curve analysis. Results: Among 887 patients with sepsis, 196 met the inclusion criteria. The ICU mortality rate was 43.9%, and the median time between pre- and post-treatment measurements was 4 days (IQR: 3–5). After hemadsorption therapy, IG count, IG%, inflammatory parameters, lactate levels, SOFA scores, and vasopressor requirements decreased (all p-values < 0.001). IG parameters were higher in non-survivors. Post-treatment IG# (AUC 0.880) and IG% (AUC 0.812) showed good discriminative performance. Conclusions: Hemadsorption therapy was associated with reductions in IG parameters and inflammatory indicators in sepsis. These findings support IG parameters as complementary measures of immune and inflammatory dynamics during hemadsorption therapy. Accordingly, this study should be regarded as a hypothesis-generating investigation describing associations of IG dynamics in septic patients undergoing hemadsorption, rather than demonstrating treatment efficacy or causal effects.
- 27 January 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (3) , 1011
Open AccessImmature Granulocyte Trajectories Following Hemadsorption as Indicators of Immune Dysregulation and Mortality
Background: Sepsis is a life-threatening condition characterized by a dysregulated host response to infection. Hemadsorption therapies remove inflammatory mediators and are used as adjunctive treatment in selected patients. Although increased immature granulocyte (IG) levels correlate with inflammatory severity, changes in IG levels after hemadsorption therapy have not been previously evaluated. Methods: This retrospective observational study included patients with sepsis who received hemadsorption therapy in intensive care units between January 2021 and July 2025. Sepsis was diagnosed according to the Surviving Sepsis Campaign 2021 guidelines, and hemadsorption was initiated for persistent hemodynamic instability despite standard therapy. Treatment was performed using a Jafron HA330 cartridge for at least three 6 h sessions. IG count and percentage, inflammatory parameters, lactate levels, and organ dysfunction scores were recorded before and after therapy. ICU mortality was the primary outcome. Statistical analyses included paired comparisons, multivariable logistic regression, and ROC curve analysis. Results: Among 887 patients with sepsis, 196 met the inclusion criteria. The ICU mortality rate was 43.9%, and the median time between pre- and post-treatment measurements was 4 days (IQR: 3–5). After hemadsorption therapy, IG count, IG%, inflammatory parameters, lactate levels, SOFA scores, and vasopressor requirements decreased (all p-values < 0.001). IG parameters were higher in non-survivors. Post-treatment IG# (AUC 0.880) and IG% (AUC 0.812) showed good discriminative performance. Conclusions: Hemadsorption therapy was associated with reductions in IG parameters and inflammatory indicators in sepsis. These findings support IG parameters as complementary measures of immune and inflammatory dynamics during hemadsorption therapy. Accordingly, this study should be regarded as a hypothesis-generating investigation describing associations of IG dynamics in septic patients undergoing hemadsorption, rather than demonstrating treatment efficacy or causal effects.